Blockade of mitogen-activated protein kinase cascade signaling in interleukin 6-independent multiple myeloma cells

Clinical Cancer Research

Volumn 3, Issue 6, 1997, Pages 1017-1022

  Ogata, Atsushi ^a   Chauhan, Dharminder ^a   Urashima, Mitsuyoshi ^a   Teoh, Gerrard ^a   Treon, Steven P ^a   Anderson, Kenneth C ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CELL DIVISION; GRB2 ADAPTOR PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; INTERLEUKIN-6; MICE; MULTIPLE MYELOMA; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASES; PROTEIN-TYROSINE-PHOSPHATASE; PROTEINS; RAS GUANINE NUCLEOTIDE EXCHANGE FACTORS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030948787     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., Kuramoto, A., and Kishimoto, T. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature (Lond.), 332: 83-85, 1988.
2. Klein, B., Zhang, X. G., Jourdan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M., and Bataille, R. Paracrine rather than autocrine regulation of myeloma cell growth and differentiation by interleukin-6. Blood, 73: 517-526, 1989.
3. Ahsmann, E. J., Lokhorst, H. M., Dekker, A. W., and Bloem, A. C. Lymphocyte function-associated antigen-1 expression on plasma cells correlates with tumor growth in multiple myeloma. Blood, 79: 2068-2075, 1992.
4. Uchiyama, H., Barut, B. A., Mohrbacher, A. F., Chauhan, D., and Anderson, K. C. Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. Blood, 82: 3712-3720, 1993.
5. Anderson, K. C., Jones, R. M., Morimoto, C., Leavitt, P., and Barut, B. C. Response patterns of purified myeloma cells to hematopoietic growth factors. Blood, 73: 1915-1924, 1989.
6. Akira, T., Taga, T., and Kishimoto, T. Interleukin-6 in biology and medicine. Adv. Immunol., 54: 1-78, 1993.
7. Kishimoto, T., Akira, S., Narazaki, M., and Taga, T. Interleukin-6 family of cytokines and gp130. Blood, 86: 1243-1254, 1995.
8. Kishimoto, T., Taga, T., and Akira, S. Cytokine signal transduction. Cell, 76: 253-262, 1994.
9. Bonni, A., Frank, D. A., Schindler, C., and Greenberg, M. E. Characterization of a pathway for ciliary neurotropic factor signaling to the nucleus. Science (Washington DC), 262: 1575-1579, 1993.
10. Lütticken, C., Wegenka, U. M., Yuan, J., Buschmann, J., Schindler, C., Ziemiecki, A., Harpur, A. G., Wilks, A. F., Yasukawa, K., Taga, T., Kishimoto, T., Barbieri, G., Pellegrini, S., Sendtner, M., Heinrich, P. C., and Horn, F. Association of transcription factor APRF and protein kinase JAK1 with the interleukin-6 signal transducer gp130. Science (Washington DC), 263: 89-92, 1994.
11. Boulton, T. G., Stahl, N., and Yancopoulos, G. D. Ciliary neurotropic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors. J. Biol. Chem., 269: 11648-11655, 1994.
12. Nakafuku, M., Satoh, T., and Kaziro, Y. Differentiation factors, including nerve growth factor, fibroblast growth factor, and interleukin-6, induce an accumulation of an active RAS-GTP complex in rat pheochromocytoma PC12 cells. J. Biol. Chem., 267: 19448-19454, 1992.
13. Daeipour, M., Kumar, G., Amaral, M. C., and Nel, A. E. Recombinant IL-6 activates p42 and p44 mitogen-activated protein kinases in the IL-6 responsive B cell line, AF10. J. Immunol., 150: 4743-4753, 1993.
14. shc, Raf-1 and MEK-1 in the IL-6-induced mitogen-activated protein kinase cascade of a growth-responsive B cell line. J. Immunol., 153: 4436-4447, 1994.
15. Nakajima, T., Kinoshita, S., Sasagawa, T., Sasaki, K., Naruto, M., Kishimoto, T., and Akira, S. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL-6. Proc. Natl. Acad. Sci. USA, 90: 2207-2211, 1993.
16. Billadeau, D., Jelinek, D. F., Shah, N., LeBien, T. W., and Ness, B. V. Introduction of an activated N-ras oncogene alters the growth characteristic of the interleukin 6-dependent myeloma cell line ANBL-6. Cancer Res., 55: 3640-3646, 1995.
17. Neumann, C., Zehentmaier, G., Danhauser-Ridell, S., Emmerich B., and Hallek, M. Interleukin-6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP-1. Eur. J. Immunol., 26: 379-384, 1996.
18. Matsuoka, Y., Moore, G., Yagi, Y., and Pressman, D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc. Soc. Exp. Biol. Med., 125: 1246-1250, 1967.
19. Nilsson, K., Bennich, H., Johansson, S., and Ponten, J. Established immunoglobulin producing myeloma (IgE) and lymphoblastic (IgG) cell lines from an IgE myeloma patient. Clin. Exp. Immunol., 7: 477-489, 1970.
20. Hitzler, J. K., Martinez-Valdez, H., Bergsagel, D. B., Minden, M. D., and Messner, H. A. Role of intcrlcukin-6 in the proliferation of human multiple myeloma cell lines OCI-My 1 to 7 established from patients with advanced stage of the disease. Blood, 78: 1996-2004, 1991.
21. Aarden, L. A., De Groot, E. R., Schaap, O. L., and Lansdorp, P. M. Production of hybridoma growth factor by human monocytes. Eur. J. Immunol., 17: 1411-1416, 1987.
22. Minami, M., Inoue, M., Wei, S., Takeda, K., Matsumoto, M., Kishimoto, T., and Akira, S. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc. Natl. Acad. Sci. USA, 93: 3963-3966, 1996.
23. Nakajima K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiuchi, N., Kitaoka, T., Fukada, T., Hibi, M., and Hirano, T. Central role for stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J., 15: 3651-3658, 1996.
24. Baltensperger, K., Kozma, L. K., Cherniack, A. D., Klarlund, J. K., Chawla, A., Banerjee, U., and Czech, M. P. Binding of the Ras activator Son of sevenless to insulin receptor substrate-1 signaling complex. Science (Washington DC), 260: 1950-1952, 1993.
25. ras through the formation of a complex of receptor. Grb2 adapter protein, and Sos nucleotide exchanger factor. Cell, 73: 611-620, 1993.
26. Langlois, W. J., Sasaoka, T., Saltiel, A. R., and Olefsky, J. M. Negative feedback regulation and desensitization of insulin and epidermal growth factor stimulated p21ras activation. J. Biol. Chem., 270: 25320-25323, 1995.
27. Chauhan, D., Karabanda, S., Ogata, A., Urashima, M., Teoh, G., Robertson, M., Kufe, D. W., and Anderson, K. C. Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells. Blood, 89: 227-234, 1997.
28. Futscher, B., and Dalton, W. Ras mutations and IL-6 dependence in human myeloma cell lines. Proc. Am. Assoc. Cancer Res., 32: A277, 1991.
29. Ogata, A., and Anderson, K. C. Therapeutic strategies for inhibition of interleukin-6 mediated multiple myeloma cell growth. Leuk. Res., 20: 303-307, 1996.
30. Sporeno, E., Savino, R., Ciapponi, L., Paonessa, G., Cabibbo, A., Lahm, A., Pulkki, K., Sun, R. X., Tonaiatti, C., Klein, B., and Ciliberto, G. Human interleukin-6 super-antagonists with high potency and wide spectrum on multiple myeloma cells. Blood, 87: 4510-4519, 1996.